Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)
Cedrés, S, Montero, M.A, Martinez, P, Martinez, A, Rodríguez-Freixinós, V, Torrejon, D, Gabaldon, A, Salcedo, M, Ramon y Cajal, S, Felip, E
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2012)
Get full text
Journal Article
Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients
Rodriguez-Freixinos, V., Lheureux, S., Mandilaras, V., Clarke, B., Dhani, N.C., Mackay, H., Butler, M.O., Wang, L., Siu, L.L., Kamel-Reid, S., Stockley, T., Bedard, P.L., Oza, A.M.
Published in Gynecologic oncology (01.05.2019)
Published in Gynecologic oncology (01.05.2019)
Get full text
Journal Article
Avelumab in unresectable/metastatic, progressive, grade 2–3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials
Chan, D.L., Rodriguez-Freixinos, V., Doherty, M., Wasson, K., Iscoe, N., Raskin, W., Hallet, J., Myrehaug, S., Law, C., Thawer, A., Nguyen, K., Singh, S.
Published in European journal of cancer (1990) (01.07.2022)
Published in European journal of cancer (1990) (01.07.2022)
Get full text
Journal Article
Outcomes of ovarian clear cell carcinoma (OCCC) of the Vall d’Hebron Hospital/Vall d’Hebron Institute of Oncology (VHIO)
Amair Pinedo, F., Fariñas-Madrid, L., Rodriguez Freixinos, V., Ros Montañá, F.J., Villacampa, G., Dienstmann, R., Oaknin, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients
Rodriguez-Freixinos, V., Fariñas-Madrid, L., Gil-Martin, M., Barretina-Ginesta, P., Romeo, M., Villacampa, G., Pardo, B., Ahmed, H., Recalde, S., Piulats, J.M., Gómez-Plaza, M.C., Gil-Moreno, A., Sala, E., Martínez-Román, S., Ponce, J., Meléndez, C., Carballas, E., Dienstmann, R., Oaknin, A.
Published in Gynecologic oncology (01.02.2019)
Published in Gynecologic oncology (01.02.2019)
Get full text
Journal Article
Achievement of complete response (CR) in metastatic or recurrent cervical cancer (MRCC): Does it matter?
Grau Béjar, J.F., Rodriguez Freixinos, V., Fariñas Madrid, L., Villacampa, G., Gil, A., Verges, R., Perez Benavente, M.A., García, A., Dienstmann, R., Oaknin, A.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Corrigendum to ‘Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients’ [Gynecologic Oncology 152 (2019) 270-277]
Rodriguez-Freixinos, V., Fariñas-Madrid, L., Gil-Martin, M., Barretina-Ginesta, P., Romeo, M., Villacampa, G., Pardo, B., Ahmed, H., Recalde, S., Piulats, J.M., Gomez-Plaza, M.C., Gil-Moreno, A., Sala, E., Martínez-Roman, S., Ponce, J., Melendez, C., Carballas, E., Dienstmann, R., Oaknin, A.
Published in Gynecologic oncology (01.01.2020)
Published in Gynecologic oncology (01.01.2020)
Get full text
Journal Article
Refining criteria of hyperprogression (HPD) with immune checkpoint inhibitors (ICIs) to improve clinical applicability
Matos Garcia, I., García Ruiz, A., Martin-Liberal, J., Hierro, C., Ochoa De Olza Amat, M., Viaplana, C., Mur, G., Vieito Villar, M., Brana, I., Azaro, A., Perez, C., Rodriguez Freixinos, V., Argiles, G., Oliveira, M., Felip Font, E., Muñoz-Couselo, E., Tabernero, J., Dienstmann, R., Garralda, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
SEOM clinical guidelines in gestational trophoblastic disease (2017)
Santaballa, A., García, Y., Herrero, A., Laínez, N., Fuentes, J., De Juan, A., Rodriguez Freixinós, V., Aparicio, J., Casado, A., García-Martinez, E.
Published in Clinical & translational oncology (01.01.2018)
Published in Clinical & translational oncology (01.01.2018)
Get full text
Journal Article
1443 POSTER High Blood Neutrophil-to-lymphocyte Ratio as an Indicator of Poor Prognosis in Advanced Non Small Cell Lung Cancer
Castro, D. Torrejon, Cedres, S, Argiles, G, Nunez, I, Rodriguez-Freixinos, V, Mulet, N, Lara, M, Martinez, P, Tabernero, J, Felip, E
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
33P Anti-tumor effect of Debio 0432, a potent and selective USP1 inhibitor, in combination with PARP inhibitors
Luong, N., Gomes, D., Lofek, S., Freixinos, V. Rodriguez
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Dynamic Contrast-Enhanced CT and MRI to Evaluate Response in Neuroendocrine Liver Metastases Treated With Everolimus and Radiation
Hudson, J.M., Singh, S., Milot, L., Patel, C., Bailey, C., Rodriguez-Freixinos, V., Chan, D., Hallet, J., Law, C.H.L., Myrehaug, S.D.
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Get full text
Journal Article
968POutcomes of ovarian clear cell carcinoma (OCCC) of the Vall d'Hebron Hospital/Vall d'Hebron Institute of Oncology (VHIO)
Amair Pinedo, F, Fariñas-Madrid, L, Rodriguez Freixinos, V, Ros Montañá, F J, Villacampa, G, Dienstmann, R, Oaknin, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
255OAchievement of complete response (CR) in metastatic or recurrent cervical cancer (MRCC): Does it matter?
Grau Béjar, J F, Rodriguez Freixinos, V, Fariñas Madrid, L, Villacampa, G, Gil, A, Verges, R, Perez Benavente, M A, García, A, Dienstmann, R, Oaknin, A
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
988PBenefit from subsequent conventional cytotoxic chemotherapy (CTx) to immunotherapy (IT) in patients (pts) with gynaecological malignancies (GM)
Ros Montañá, F J, Rodriguez Freixinos, V, Fariñas Madrid, L, Amair Pinedo, F, Ruiz-Pace, F, Garralda, E, Dienstmann, R, Oaknin, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Achievement of complete response (CR) in metastatic or recurrent cervical cancer (MRCC): Does it matter?
Grau Béjar, J.F., Rodriguez Freixinos, V., Fariñas Madrid, L., Villacampa Javierre, G., Gil-Moreno, A., Verges, R., Pérez Benavente, M.A., García, A., Dienstmann, R., Oaknin, A.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
1062TiPA phase II study of pembrolizumab in combination with doxorubicin in advanced, recurrent or metastatic endometrial cancer
Oaknin, A, Perez, M J Rubio, Madrid, L Fariñas, Redondo, A, Esteban, A Yubero, Martín, M Gil, Martín, A González, Romero, I, Garcia-Donas, J, Serrano, R, Martínez, A Gallego, Diez, M Ocariz, Lorenzo, M L Sanchez, De La Maza Lopez Olmedo, M D Fenor, Freixinos, V Rodriguez, Rodriguez, J M Piulats
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1062TiP - A phase II study of pembrolizumab in combination with doxorubicin in advanced, recurrent or metastatic endometrial cancer
Oaknin, A., Perez, M J Rubio, Madrid, L Fariñas, Redondo, A., Esteban, A Yubero, Martín, M Gil, Martín, A González, Romero, I., Garcia-Donas, J., Serrano, R., Martínez, A Gallego, Diez, M Ocariz, Lorenzo, M L Sanchez, De La Maza Lopez Olmedo, M D Fenor, Freixinos, V Rodriguez, Rodriguez, J M Piulats
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase II study of pembrolizumab in combination with doxorubicin in advanced, recurrent or metastatic endometrial cancer
Oaknin, A., Perez, M J Rubio, Madrid, L Fariñas, Redondo, A., Esteban, A Yubero, Martín, M Gil, Martín, A González, Romero, I., Garcia-Donas, J., Serrano, R., Martínez, A Gallego, Diez, M Ocariz, Lorenzo, M L Sanchez, De La Maza Lopez Olmedo, M D Fenor, Freixinos, V Rodriguez, Rodriguez, J M Piulats
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1841PRefining criteria of hyperprogression (HPD) with immune checkpoint inhibitors (ICIs) to improve clinical applicability
Matos Garcia, I, García Ruiz, A, Martin-Liberal, J, Hierro, C, Ochoa De Olza Amat, M, Viaplana, C, Mur, G, Vieito Villar, M, Brana, I, Azaro, A, Perez, C, Rodriguez Freixinos, V, Argiles, G, Oliveira, M, Felip Font, E, Muñoz-Couselo, E, Tabernero, J, Dienstmann, R, Garralda, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article